Karnataka pharma’s adherence to robust quality systems indicate need for gap analysis minimal: Nandita Vijayasimha, Bengaluru Friday, June 6, 2025, 08:00 Hrs [IST] Karnataka pha ...

Explore the future of the pharmaceutical industry with this comprehensive report. Delve into key trends via regulatory, clinical, and market analyses. Essential for investors, new entrants, and pharma ...

In this issue: assessing the regulators' role as AI in clinical trials evolves, the potential for a newborn screening refresh ...

These have been dark days for the global economy, and the short-term prospects for the pharmaceutical industry look uncertain. The industry is currently undergoing change and restructuring on an ...

The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

Less than two weeks after the Senate moved to create a new prescription drug price cap system in Massachusetts, an industry official warned against legislative “leapfrog” that could ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...

According to the nonprofit news outlet NOTUS, at least seven studies cited in the Make America Healthy Again report released ...

China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on ...

Eli Lilly LLY announced plans to acquire SiteOne Therapeutics to expand its pain pipeline. Moderna MRNA announced that the ...